自己免疫性肝炎 (AIH) 診断・治療の世界市場：分析・予測
Global Autoimmune Hepatitis Diagnosis and Treatment Market Forecast, 2018-2023
|発行||Orion Market Research Pvt Ltd||商品コード||785696|
|自己免疫性肝炎 (AIH) 診断・治療の世界市場：分析・予測 Global Autoimmune Hepatitis Diagnosis and Treatment Market Forecast, 2018-2023|
|出版日: 2019年01月18日||ページ情報: 英文||
当レポートでは、世界の自己免疫性肝炎 (AIH) 診断・治療市場について調査分析し、市場概要、市場決定要因、市場区分、競合情勢、地域別分析、主要企業などについて、体系的な情報を提供しています。
Autoimmune hepatitis (AIH) is a chronic and long-lasting disease which are caused due to the immune system of the body which attacks the normal cells of the body and lead to liver damage and cirrhosis. The disease occurs due to the inherited tendency or genetic predisposition which can grow the demand for autoimmune hepatitis medication. There are mainly two types of autoimmune hepatitis which include type-I, type-II and Variant AIH. Autoimmune hepatitis can be diagnosed with different diagnosis procedure such as blood test, an imaging test, and liver biopsy. The autoimmune hepatitis treatment can be done either by medication such as corticosteroids and other immune system suppressors medicines or by a liver transplant. Presence of a wider range of product is the major driving factor for autoimmune hepatitis market. Moreover, the change in lifestyle and consumption of alcohol is leading to severe liver diseases and creating the demand for autoimmune hepatitis diagnosis and treatment across the globe.
Although, the stringent regulation for liver transplantation is the major restraining factor for the growth of the autoimmune hepatitis diagnosis and treatment market. In addition, the treatment cost is very high, and the liver transplant can cause the risk of trauma to the remaining kidney which is hindering the adoption of liver translation, thus constraining the growth of the market. Whereas, the increasing healthcare expenditure and the development of healthcare infrastructure in emerging countries will turn out to be a huge opportunity for this market. Further, the presence of strong pipeline product will also create enormous opportunities for the market in near future.
Geographically market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is growing with significant growth and is dominating the overall global autoimmune hepatitis diagnosis and treatment market. The factors that are driving the growth of the market are high consumption of alcohol and the developed infrastructure. Further, the presence of a strong market player within the region is also a major factor for its dominance. Additionally, Europe is the second largest market due to the increasing healthcare expenditure in order to provide a better quality of life. Along with it, rising awareness of organ transplant treatment and the government initiative are the major driving factor for autoimmune hepatitis market in Asia-Pacific region.
There is a large number of market players contributing in the global hepatitis diagnosis and treatment market includes Abbott Laboratories, Inc., Novartis International AG, Gilead Lifesciences, Inc., MercK & Co., Inc., Bio-Rad laboratories, Inc. and so on. These companies are continuously making efforts to stay competitive in the market. These companies are adopting various strategies such as merger & acquisition, partnership & collaboration, product launch, and geographical expansion.
The market study of autoimmune hepatitis diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
The report is intended for the pharmaceutical drug manufacturer, investing companies, Government Organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
Global autoimmune hepatitis diagnosis and treatment market are segmented on the basis of regional outlook and following segments: